US09075A1088
US09075A1088
Bioventus Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 568.087.000 | 573.280.000 | 0.9% |
| Cost of Revenue | 179.930.000 | 185.054.000 | 2.8% |
| Gross Profit | 388.157.000 | 388.226.000 | 0.0% |
| 331.866.000 | 365.401.000 | 9.2% | |
| Operating Income | 56.291.000 | 22.825.000 | 146.6% |
| Pretax Income | 25.709.000 | -52.342.000 | 149.1% |
| Net Income Common Stockholders | 22.732.000 | -36.125.000 | 162.9% |
| -- | -- | -- | |
| -- | -- | -- |